Literature DB >> 6260966

Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. I. Kinetics of synthesis and size of minus- and plus-strand transcripts.

L R Boone, A M Skalka.   

Abstract

We have examined the kinetics of synthesis of minus [(-)]- and plus [(+)]-strand viral DNA in melittin-permeabilized avian retrovirus particles. The reaction was biphasic. There was a very rapid initial rate, followed, after approximately 1 h, by a lower rate. Many discrete bands of subgenomic-length (-) strands were produced after 10 and 20 min of synthesis; genome-length (7.7-kilobase [kb]) (-) strands were detected within 30 min. Extension to an 8.0-kb (-)-strand species was evident by 60 min. This extension was inhibited by actinomycin D. Synthesis of (+) strands (which is also inhibited by actinomycin D) began early, before any (-) strands were completed, and continued for more than 4 h beyond the time when synthesis of full-length DNA had terminated. Two distinct species of (+)-strand DNA, 0.27 and 0.35 kb, could be observed at the earliest times. Their presence was quickly obscured by subsequent formation of (+)-strand molecules of molecular length between 0.2 and 2.0 kb.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260966      PMCID: PMC170987     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Partially single-stranded form of free Moloney viral DNA.

Authors:  A M Gianni; R A Weinberg
Journal:  Nature       Date:  1975-06-19       Impact factor: 49.962

2.  Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus.

Authors:  A M Gianni; D Smotkin; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

3.  Site on the RNA of an avian sarcoma virus at which primer is bound.

Authors:  J M Taylor; R Illmensee
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

4.  Ethidium bromide inhibits appearance of closed circular viral DNA and integration of virus-specific DNA in duck cells infected by avian sarcoma virus.

Authors:  R V Guntaka; B W Mahy; J M Bishop; H E Varmus
Journal:  Nature       Date:  1975-02-13       Impact factor: 49.962

5.  A primer ribonucleic acid for initiation of in vitro Rous sarcarcoma virus deoxyribonucleic acid synthesis.

Authors:  F Harada; R C Sawyer; J E Dahlberg
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

6.  DNA polymerases of Rous sarcoma virus: delineation of two reactions with actinomycin.

Authors:  J P McDonnell; A C Garapin; W E Levinson; N Quintrell; L Fanshier; J M Bishop
Journal:  Nature       Date:  1970-10-31       Impact factor: 49.962

7.  Synthesis of viral DNA in the cytoplasm of duck embryo fibroblasts and in enucleated cells after infection by avian sarcoma virus.

Authors:  H E Varmus; R V Guntaka; W J Fan; S Heasley; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

8.  Deoxyribonucleic acid polymerase(s) of Rous sarcoma virus: effects of virion-associated endonuclease on the enzymatic product.

Authors:  N Quintrell; L Fanshier; B Evans; W Levinson; J M Bishop
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

9.  Mechanism of carcinogenesis by RNA tumor viruses. 3. Formation of RNA, DNA complex and duplex DNA molecules by the DNA polymerase (s) of avian myeloblastosis virus.

Authors:  K Fujinaga; J T Parsons; J W Beard; D Beard; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

10.  Forms of deoxyribonucleic acid produced by virions of the ribonucleic acid tumor viruses.

Authors:  K F Manly; D F Smoler; E Bromfeld; D Baltimore
Journal:  J Virol       Date:  1971-01       Impact factor: 5.103

View more
  37 in total

1.  Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription.

Authors:  A Aiyar; D Cobrinik; Z Ge; H J Kung; J Leis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Effect of gamma radiation on retroviral recombination.

Authors:  W S Hu; H M Temin
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription.

Authors:  D Cobrinik; A Aiyar; Z Ge; M Katzman; H Huang; J Leis
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Relationship of avian retrovirus DNA synthesis to integration in vitro.

Authors:  Y M Lee; J M Coffin
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

6.  Replication of the retroviral terminal repeat sequence during in vivo reverse transcription.

Authors:  C A Ramsey; A T Panganiban
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors.

Authors:  W A O'Brien; A Namazi; H Kalhor; S H Mao; J A Zack; I S Chen
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

8.  Efficient autointegration of avian retrovirus DNA in vitro.

Authors:  Y M Lee; J M Coffin
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

9.  A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro.

Authors:  E Bieth; C Gabus; J L Darlix
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

10.  Extended minus-strand DNA as template for R-U5-mediated second-strand transfer in recombinational rescue of primer binding site-modified retroviral vectors.

Authors:  J G Mikkelsen; A H Lund; K Dybkaer; M Duch; F S Pedersen
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.